Beckman Coulter's Early Sepsis Indicator Receives 510(k) Clearance from the U.S. Food and Drug Administration

New hematologic biomarker has the potential to revolutionize clinicians' approach to sepsis triage and diagnosis BREA, Calif., April 18, 2019 -- (Healthcare Sales & Marketing Network) -- A major milestone on its strategic mission to lead in sepsis diag... Devices, Diagnostics, FDA Beckman Coulter, Early Sepsis Indicator
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news